![]() ![]() “Laboratories that bill for medically unnecessary tests drain funds from Medicare and other federally funded health care programs,” said United States Attorney Rachael S. Inform submitted these medically unnecessary tests for payment, causing federal health care programs to pay for false claims. ![]() The United States contends that Inform’s policy of conducting routine additional tests caused Inform to perform many tests that were medically unnecessary. On April 27, 2022, Fulgent Genetics purchased Inform, and the company is now a wholly owned subsidiary of Fulgent Genetics.Īccording to the settlement, Inform admits that, between 20, it routinely and automatically conducted additional tests on biopsy specimens prior to a pathologist’s review and without an individualized determination regarding whether additional tests were medically necessary. Inform is a clinical laboratory headquartered in Irving, Texas, that provides anatomic pathology services to physician practices throughout the United States. (Inform), has agreed to pay $16 million to resolve allegations that it submitted false claims for payment to Medicare and other federal health care programs. The United States press release concerning the settlement can be read here.BOSTON – Inform Diagnostics, Inc., (Inform) formerly known as Miraca Life Sciences, Inc. The settlement agreement in this case can be found here. Wallace for shedding light on Inform's reflexive testing practices," stated fellow Morgan Verkamp partner Chandra Napora. "When laboratories conduct medically unnecessary testing, they put profit over the fiscal soundness of our healthcare system. Their dedication to take that risk in the interest of protecting taxpayers and the public fisc is inspiring," said Sonya Rao, a partner at Morgan Verkamp. Wallace, take significant personal and professional risk to sound the alarm on fraud schemes. In the settlement, Inform admits that, from Januthrough January 31, 2018, Inform routinely and automatically conducted certain up-front stains on gastrointestinal and dermatological biopsy specimens without a pathologist's review of the routine stain and without an individual determination of whether the additional stain was medically necessary. Wallace.Īs part of the settlement, Inform has agreed to pay the United States $16 million. That investigation resulted in a settlement of False Claims Act allegations raised by Dr. The United States Attorney's Office for the District of Massachusetts led the investigation into Dr. Rather than perform only the laboratory tests ordered by physicians, Inform automatically and systematically ran additional tests, including special stains, without the treating physician's knowledge, consent, or order and without a pathologist's determination of medical necessity. The complaint alleged that Inform submitted false claims to federal healthcare programs, like Medicare, for medically unnecessary laboratory testing. The matter was filed in the United States District Court for the District of Massachusetts. Inform Diagnostics, Inc., and the case number is 19-cv-10091. Wallace, a former pathologist at Inform, filed suit against the laboratory in January 2019, alleging violations of the False Claims Act, a law that allows whistleblowers to bring a case on behalf of the United States that alleges fraud on the government. Inform is a clinical laboratory, headquartered in Irving, Texas, that provides clinical pathology laboratory services to physicians and medical practices nationwide.ĭr. Christopher Wallace, the law firm of Morgan Verkamp, LLC (with attorneys in Cincinnati, Ohio, Boston, Massachusetts, and Tampa, Florida) is pleased to announce that the United States has resolved allegations of medically unnecessary pathology testing with Inform Diagnostics, Inc., formerly known as Miraca Life Sciences, Inc. BOSTON and CINCINNATI, J/PRNewswire/ - On behalf of its client, Dr. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |